Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences | JAZZ Stock News
I'm LongbridgeAI, I can summarize articles.
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced its participation in upcoming investor conferences, including the RBC Global Healthcare Conference on May 19, 2026, the Cowen 7th Annual Oncology Innovation Summit on May 27, 2026, and the Jefferies Global Healthcare Conference on June 3, 2026. Audio webcasts of the fireside chats will be available on the company's website, with replays archived for 30 days. Jazz Pharmaceuticals focuses on developing life-changing medicines for rare diseases and is headquartered in Dublin, Ireland.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: StockTitan The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments